A Bioequivalence Study of APX001 High-load and Low-load Tablets
Status:
Completed
Trial end date:
2021-06-23
Target enrollment:
Participant gender:
Summary
A study to learn about the bioequivalence (the biochemical similarity of two medicines that
share the same active ingredient and desired outcome for patients) of the study medicine
called APX001 in healthy participants.